CPT 83001: Follicle Stimulating Hormone (FSH) Quantitative Assay
Commercial payers pay $47 on average nationally for this procedure.
CPT code 83001 describes a laboratory quantitative assay for follicle stimulating hormone (FSH), performed on a serum specimen to evaluate pituitary regulation of ovarian or testicular function; service type: clinical laboratory testing; typical site of service: outpatient laboratory or hospital laboratory/clinical pathology department.
For related coverage guidance, see recent payer policy updates: Salivary Hormone Testing, Bone Turnover Markers Testing, Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing.
Customize your policy alerts
Sign up for cpt 83001 policy alerts
Get alerted when payer policies referencing 83001 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Commercial reimbursement for CPT 83001 centers around BUCA’s average commercial rate of $46.9, with individual payers displaying distinct centering and spread. Blue Cross Blue Shield posts the highest variability and top-end rates (max $238.1) while also clustering high around its $60.5 median; Aetna and Cigna sit lower on medians ($17 and $17.9 respectively) but differ in spread and tails. UnitedHealth Group has a lower median of $11.2 and a moderate mean of $16.6.
Dispersion measured as P75 minus P25 highlights variability: Blue Cross Blue Shield’s interquartile range is $24.7 ($80.0 − $53.3), the widest among listed payers, indicating greater middle-range spread; UnitedHealth Group is relatively tight with an IQR of $9.6 ($18.6 − $8.4). Aetna’s IQR is $12.9 and Cigna’s is $15.6, placing them between the tightness of UnitedHealth Group and the breadth of Blue Cross Blue Shield.